1. Home
  2. BRZE vs IOVA Comparison

BRZE vs IOVA Comparison

Compare BRZE & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braze Inc.

BRZE

Braze Inc.

HOLD

Current Price

$33.27

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.21

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRZE
IOVA
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
968.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BRZE
IOVA
Price
$33.27
$2.21
Analyst Decision
Strong Buy
Buy
Analyst Count
20
12
Target Price
$44.70
$10.36
AVG Volume (30 Days)
2.1M
9.8M
Earning Date
12-09-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$693,412,000.00
$250,425,000.00
Revenue This Year
$23.36
$60.94
Revenue Next Year
$17.31
$60.85
P/E Ratio
N/A
N/A
Revenue Growth
22.95
175.62
52 Week Low
$23.91
$1.64
52 Week High
$48.33
$8.56

Technical Indicators

Market Signals
Indicator
BRZE
IOVA
Relative Strength Index (RSI) 63.64 46.56
Support Level $27.76 $2.18
Resistance Level $37.33 $2.32
Average True Range (ATR) 1.27 0.12
MACD 0.65 -0.01
Stochastic Oscillator 59.70 18.11

Price Performance

Historical Comparison
BRZE
IOVA

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: